Skip to content

Rapid Micro Biosystems RPID Warrant liability

Warrant liability at other companies

QT Imaging Holdings, Inc. logo
QT Imaging Holdings, Inc.QTI
$276K-98.6%
SHA
SharonAI Holdings, Inc. Class A Common StockSHAZ
$6.68K
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$9.58M-46.2%
The RealReal logo
The RealRealREAL
$56.11M+55.5%
SLD
Solid PowerSLDP
$4.24M+48.5%
Bakkt
 logo
Bakkt BKKT
$12.03M-18.0%

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.5%
Enterprise value$95.86M-31.3%
P/S2.5×-2.5×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept rmb:WarrantLiabilityNoncurrent.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's warrant liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's warrant liability?
Rapid Micro Biosystems (RPID) reported warrant liability of $116K in Q1 2026.
What does warrant liability mean?
This represents the fair value of outstanding warrants that are classified as liabilities rather than equity, typically due to specific settlement provisions. Because these liabilities are marked-to-market, changes in the company's stock price can lead to significant non-cash volatility in the income statement. Investors monitor this to understand potential dilution risks and the impact of derivative accounting on reported earnings.